These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5377003)

  • 1. [Changes of plasma free fatty acids associated with diabetes treated by glyconormal: 30 clinical cases].
    Warembourg H; Jaillard J
    Journ Annu Diabetol Hotel Dieu; 1969; 10():431-4. PubMed ID: 5377003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Normal plasma free fatty acid (C 16 -C 18 ) values in diabetics after treatment with an oral hypoglycemizing agent].
    Bertolini AM; Santagostino A
    Minerva Med; 1972 Mar; 63(20):1145-9. PubMed ID: 5018858
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental and clinical studies of the antidiabetic action of dipotassium rhodizonate (CPK-2)].
    Kuniyoshi A
    Nihon Ika Daigaku Zasshi; 1970 Aug; 37(4):310-23. PubMed ID: 5478470
    [No Abstract]   [Full Text] [Related]  

  • 5. Free fatty acid receptor family: novel targets for the treatment of diabetes and dyslipidemia.
    Bernard J
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1078-83. PubMed ID: 18821469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
    Iaroshevskiĭ IuA; Volkova EA
    Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fundamentals of diabetes regulation in urgent and planned surgical operations].
    Beringer A; Mösslacher H; Tragl KH
    Wien Klin Wochenschr; 1968 Jul; 80(29):573-7. PubMed ID: 5705693
    [No Abstract]   [Full Text] [Related]  

  • 8. [Attempts of modification of the serum lipid fractions in diabetics].
    Krámer M; Balogh P
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):345-51. PubMed ID: 5731589
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of free fatty acids on the course of gestational diabetes mellitus.
    Bomba-Opon D; Wielgos M; Szymanska M; Bablok L
    Neuro Endocrinol Lett; 2006; 27(1-2):277-80. PubMed ID: 16648799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy.
    Masoudi FA; Inzucchi SE
    Am J Cardiol; 2007 Feb; 99(4A):113B-132B. PubMed ID: 17307064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free fatty acid and triglyceride content of the blood in newly-detected diabetes mellitus with prolonged preservation of normoglycemia as a result of diet therapy in combination with sulfanilamide antidiabetic preparations].
    Bogatyreva ShI; Dzeranova NIa; Zaripova ZKh
    Probl Endokrinol (Mosk); 1973; 19(1):3-7. PubMed ID: 4698453
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in myocardial metabolism in the diabetic myocardium.
    Lazar HL
    Semin Thorac Cardiovasc Surg; 2006; 18(4):289-92. PubMed ID: 17395024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of therapy and adjustment of diabetics with xanthine nicotinate].
    Hahn J; Kaffarnik H
    Med Klin; 1969 May; 64(22):1042-5. PubMed ID: 5800195
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets].
    Crespo J; Cayón A; Pons-Romero F
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():15-23. PubMed ID: 15195530
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diabetes mellitus. Present concepts and therapeutic implications].
    de L'Hortet GC; Bercovici JP
    Presse Med (1893); 1968 Dec; 76(50):2389-92. PubMed ID: 5734286
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in plasma levels of nonesterified fatty acids in diabetes studied by titrimetric and colorimetric assay].
    Warembourg H; Biserte G; Jaillard J; Sezille G; Bertrand M
    Diabete; 1969; 17(3):198-204. PubMed ID: 5360796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in diabetic plasma levels of free fatty acids studied by titrimetric and colorimetric assay].
    Warembourg H; Biserte G; Jaillard J; Sezille G; Bertrand M
    Diabete; 1968; 16(3):198-204. PubMed ID: 5760689
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucagon test in diabetics: its significance and its changes after treatment with Glybenclamide].
    Adezati L; De Lorenzi F; Prando R; Fresco G; Pagliaini R; Amore R
    Acta Diabetol Lat; 1969; 6(2):247-82. PubMed ID: 5397407
    [No Abstract]   [Full Text] [Related]  

  • 19. [Improvement of oral glucose tolerance through acute medicamentous reduction of free fatty acids in the plasma].
    Büber V; Felber JP; Vannotti A
    Schweiz Med Wochenschr; 1968 May; 98(19):711-3. PubMed ID: 5700753
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma insulin and metabolic study on diabetes treated with glibenclamide.
    Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlinson RW; Woodroffe F
    Postgrad Med J; 1970 Dec; ():Suppl:36-41. PubMed ID: 5533294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.